These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4700011)

  • 1. Amiloride in primary hyperaldosteronism with chronic peptic ulceration.
    Kremer D; Fraser R; Brown JJ; Lever AF; Davies DL; Robertson JI
    Br Med J; 1973 Apr; 2(5860):216-7. PubMed ID: 4700011
    [No Abstract]   [Full Text] [Related]  

  • 2. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 3. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of amiloride as a potassium conserving agent in severe cardiac disease.
    Davidson C; Gillebrand IM
    Br Heart J; 1973 Apr; 35(4):456-61. PubMed ID: 4702377
    [No Abstract]   [Full Text] [Related]  

  • 5. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the potassium- retaining effects of amiloride and spironolactone in hypertensive patients with thiazide-induced hypokalaemia.
    George CF; Breckenridge AM; Dollery CT
    Lancet; 1973 Dec; 2(7841):1288-91. PubMed ID: 4127641
    [No Abstract]   [Full Text] [Related]  

  • 7. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiloride in primary hyperaldosteronism.
    Griffing GT; Cole AG; Aurecchia SA; Sindler BH; Komanicky P; Melby JC
    Clin Pharmacol Ther; 1982 Jan; 31(1):56-61. PubMed ID: 7053305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870).
    McNay JL; Oran E
    Metabolism; 1970 Jan; 19(1):58-70. PubMed ID: 5410663
    [No Abstract]   [Full Text] [Related]  

  • 11. Amiloride hydrochloride in hypertensive patients.
    Paterson JW; Dollery CT; Haslam RM
    Br Med J; 1968 Feb; 1(5589):422-3. PubMed ID: 5639627
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of amiloride combined with hydrochlorothiazide (Moduretic) in the treatment of hypertension.
    Seedat YK; Naidoo DN
    S Afr Med J; 1973 Jul; 47(28):1219-21. PubMed ID: 4721040
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of the hypertensive patient. Value of Amiloride during saldiuretic treatment].
    Meyer P; Milliez P
    Nouv Presse Med; 1972 Sep; 1(32):2121-2. PubMed ID: 5082245
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of amiloride hydrochloride in the correction of hypokalaemic alkalosis induced by diuretics.
    Antcliff AC; Beevers DG; Hamilton M; Harpur JE
    Postgrad Med J; 1971 Oct; 47(552):644-7. PubMed ID: 5158837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amiloride on metabolic alkalosis and hypokalaemia after cardiopulmonary bypass surgery.
    Hocking MA; Bain WH
    Br Heart J; 1974 Jun; 36(6):597-602. PubMed ID: 4851604
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of moduretic and hydrochlorothiazide in the treatment of hypertension in African patients.
    Salako LA; Falase AO
    East Afr Med J; 1973 Jan; 50(1):38-47. PubMed ID: 4720446
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical changes during moduretic treatment of hypertension in African patients.
    Ahaneku JE; Taylor GO; Walker O; Agbedana EO; Salako LA
    Kobe J Med Sci; 1995 Aug; 41(4):83-93. PubMed ID: 8904160
    [No Abstract]   [Full Text] [Related]  

  • 18. A clinical study of Co-hydroDiuril a combination of an antikaliuretic (amiloride) and hydrochlorothiazide.
    Nash DT
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):576-82. PubMed ID: 4263887
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spirolactones and potassium-sparing diuretics].
    Thibonnier M; Corvol P; Milliez P
    Rev Prat; 1978 Nov; 28(51):4021-4, 4027-8, 4031-2. PubMed ID: 741188
    [No Abstract]   [Full Text] [Related]  

  • 20. The antihypertensive and diuretic effects of amiloride and of its combination with hydrochlorothiazide.
    Kampffmeyer H; Conway J
    Clin Pharmacol Ther; 1968; 9(3):350-4. PubMed ID: 4870256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.